Inhibition of lipogenesis

Details Inhibition of lipogenesis Inhibition of lipogenesis

1988-07-08

1990-08-28

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514211, 514669, 514 25, 514909, 536 179, 536 187, 536 540, 536 550, 536 551, A61K 3170, A61K 31715, A61K 3173

Patent

active

049525670

ABSTRACT:
A process which comprises administering an antagonist of protein kinase C and/or the insulin receptor tyrosine kinase to a mammal in an amount therapeutically effective to inhibit lipogenesis in the mammal.

REFERENCES:
patent: 4004030 (1977-01-01), Schwarzmann et al.
patent: 4476119 (1984-10-01), della Valle et al.
patent: 4593091 (1986-06-01), della Valle et al.
patent: 4731210 (1988-03-01), Weder et al.
patent: 4735939 (1988-04-01), McCoy et al.
Moody et al., Horm. Metab. Res., 1974, vol. 6, pp. 12-16.
Gliemann et al., Diabetologia, 1974, vol. 10, pp. 105-113.
Freychet et al., Diabetologia, 1974, vol. 10, pp. 1-5.
Keefer et al., Proc. Natl. Acad. Sci., 1981, vol. 78(3), pp. 1391-1395.

Affiliated with

Also associated with

Rating

Inhibition of lipogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of lipogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of lipogenesis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1589933